Cargando…

Lung cancer drug therapy in Hungary – 3-year experience

Hungary is a world leader in lung cancer deaths, so it is of crucial importance that patients have access to modern treatments. The aim of our analysis was to explore how drug treatments are used in Hungary and how they are compatible with international practice. The inpatient and prescription datab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moldvay, Judit, Rokszin, György, Abonyi-Tóth, Zsolt, Katona, Lajos, Fábián, Katalin, Kovács, Gábor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435090/ https://www.ncbi.nlm.nih.gov/pubmed/25999737 http://dx.doi.org/10.2147/OTT.S65794

Ejemplares similares

Persistence with statin therapy in Hungary
por: Kiss, Zoltan, et al.
Publicado: (2013)

Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary
por: Bogos, Krisztina, et al.
Publicado: (2019)

Increase in the Length of Lung Cancer Patient Pathway Before First-Line Therapy: A 6-Year Nationwide Analysis From Hungary
por: Kiss, Zoltan, et al.
Publicado: (2021)

Significant changes in advanced lung cancer survival during the past decade in Hungary: impact of modern immunotherapy and the COVID-19 pandemic
por: Kiss, Zoltán, et al.
Publicado: (2023)

Different Changes of Risks for Stroke and Myocardial Infarction in Patients With Type 2 Diabetes in Hungary Between the Two Periods of 2001–2004 and 2010–2013
por: Kiss, Zoltan, et al.
Publicado: (2019)

Dissimilar impact of type 2 diabetes on cardiovascular outcomes according to age categories: a nationwide population study from Hungary
por: Kiss, Zoltán, et al.
Publicado: (2018)

Demographic Characteristics and Treatment Patterns Among Patients Receiving Palbociclib for HR+/HER2− Advanced Breast Cancer: A Nationwide Real-World Experience
por: Boér, Katalin, et al.
Publicado: (2021)

Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: Trends from 2011 Through 2016
por: Tamási, Lilla, et al.
Publicado: (2021)

Changing Patterns of Antihyperglycaemic Treatment among Patients with Type 2 Diabetes in Hungary between 2015 and 2020—Nationwide Data from a Register-Based Analysis
por: Jermendy, György, et al.
Publicado: (2022)

Changes in the incidence and prevalence of type 1 and type 2 diabetes among 2 million children and adolescents in Hungary between 2001 and 2016 – a nationwide population-based study
por: Barkai, László, et al.
Publicado: (2019)

Significant Regional Differences in Lung Cancer Incidence in Hungary: Epidemiological Study Between 2011 and 2016
por: Gálffy, Gabriella, et al.
Publicado: (2021)

Incremental cost of premature birth – a public health care payer perspective from Hungary
por: Kovács, Gábor, et al.
Publicado: (2023)

Persistence of initial oral antidiabetic treatment in patients with type 2 diabetes mellitus
por: Jermendy, György, et al.
Publicado: (2012)

Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis
por: Bogos, Krisztina, et al.
Publicado: (2021)

Underlying reasons for post-mortem diagnosed lung cancer cases – A robust retrospective comparative study from Hungary (HULC study)
por: Kiss, Zolta´n, et al.
Publicado: (2022)

Persistence to Treatment with Novel Antidiabetic Drugs (Dipeptidyl Peptidase-4 Inhibitors, Sodium-Glucose Co-Transporter-2 Inhibitors, and Glucagon-Like Peptide-1 Receptor Agonists) in People with Type 2 Diabetes: A Nationwide Cohort Study
por: Jermendy, György, et al.
Publicado: (2018)

Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011–2016
por: Bogos, Krisztina, et al.
Publicado: (2021)

Inequalities in Diabetes Mortality Between Microregions in Hungary
por: Kollányi, Zsófia, et al.
Publicado: (2023)

Medical Communication during the Transition to Palliative Care in Pediatric Oncology in Hungary—The Parents’ Perspective
por: Földesi, Enikő, et al.
Publicado: (2022)

Opinions on Insect Consumption in Hungary
por: Szendrő, Katalin, et al.
Publicado: (2020)

Late mortality in survivors of childhood cancer in Hungary
por: Jakab, Zsuzsanna, et al.
Publicado: (2020)

Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011–2020
por: Kiss, Zoltán, et al.
Publicado: (2023)

Analysis of Low Cancer Mortality Rates in the Wine Regions of Tokaj and Balaton in Hungary
por: Sipka, Sándor, et al.
Publicado: (2020)

Survival Benefits of Second-line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma
por: Géczi, Lajos, et al.
Publicado: (2020)

Physical Activity in the Southern Great Plain Region of Hungary: The Role of Sociodemographics and Body Mass Index
por: Győri, Ferenc, et al.
Publicado: (2021)

Universal newborn hearing screening with automated auditory brainstem response (AABR) in Hungary: 5-year experience in diagnostics and influence on the early intervention
por: Gáborján, Anita, et al.
Publicado: (2022)

Putative Novel Genotype of Avian Hepatitis E Virus, Hungary, 2010
por: Bányai, Krisztián, et al.
Publicado: (2012)

Clinicopathological Review of 547 Bulbar Enucleations in Hungary (2006–2017)
por: Tóth, Gábor, et al.
Publicado: (2019)

Neonatal Screening for Cystic Fibrosis in Hungary—First-Year Experiences
por: Xue, Andrea, et al.
Publicado: (2023)

Epidemiological investigations of bovine besnoitiosis in Hungary
por: Hornok, S, et al.
Publicado: (2014)

Genetic landscape of early-onset dementia in Hungary
por: Csaban, Dora, et al.
Publicado: (2022)

Improving Outcomes Achieved by a New Stroke Program in Hungary
por: Égi, Csilla, et al.
Publicado: (2015)

Adaptation of the Food Choice Questionnaire: the case of Hungary
por: Szakály, Zoltán, et al.
Publicado: (2018)

Assessment of cardiometabolic risk among shift workers in Hungary
por: Jermendy, György, et al.
Publicado: (2012)

Changing Trends in Melanoma Incidence and Decreasing Melanoma Mortality in Hungary Between 2011 and 2019: A Nationwide Epidemiological Study
por: Liszkay, Gabriella, et al.
Publicado: (2021)

Current Status of Clinical and Genetic Screening of Hereditary Hemorrhagic Telangiectasia Families in Hungary
por: Major, Tamás, et al.
Publicado: (2021)

A new ladybird spider from Hungary (Araneae, Eresidae)
por: Kovács, Gábor, et al.
Publicado: (2015)

Clinical Review of Ocular Traumas Resulting in Enucleation or Evisceration in a Tertiary Eye Care Center in Hungary
por: Tóth, Gábor, et al.
Publicado: (2021)

The Role of Identity and Ontological (In)Security in Return Migration: an Empirical Perspective from Hungary
por: Lados, Gabor, et al.
Publicado: (2022)

Characterisation of antibiotic resistance, virulence, clonality and mortality in MRSA and MSSA bloodstream infections at a tertiary-level hospital in Hungary: a 6-year retrospective study
por: Horváth, Andrea, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_at76n8m5l8e8vpngf24k0n79ts